Moderna shook the world this morning with the announcement that its COVID-19 vaccine was 94.5 percent effective in Phase 3 trials.
Health, Wellness & Biotech
The company will be finalizing its diagnostic tool, focused on ovarian cancer, for clinical use next year.
We think these startups are worth highlighting for their interesting approaches despite their smaller raises.
The firm is looking for industries that are undergoing technology disruption, where there are no incumbents, and where there is opportunity for good...